Get started
Author

M. P. Semenov

Observed names: M.P. Semenov, Michail P. Semenov, Mikhail P. Semenov
ORCID: 0000-0002-6877-4817
Observed ORCID: 0000-0002-6877-4817
OpenAlex ID: A5078442412
Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)
2022 · E.I. Gusev, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 32
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE
2024 · Alexander I. Kirienko, Stanislav G. Leontyev, et al. · Journal of Thrombosis and Haemostasis · 16
PDF
Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice
2022 · V. A. Markov, D. V. Duplyakov, et al. · Russian Journal of Cardiology · 15
PDF
Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
2024 · A. I. Kirienko, S. G. Leontyev, et al. · Russian Journal of Cardiology · 9
PDF
Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial
2025 · S. N. Tereshchenko, E. B. Yarovaya, et al. · Russian Journal of Cardiology · 7
Non-Immunogenic Staphylokinase vs Alteplase in Patients with Massive Pulmonary Embolism: the Protocol of a Multiple-Center Open-Label Randomized Trial FORPE
2022 · A.I. Kirienko, E.B. Yarovaya, et al. · Journal of Venous Disorders · 7
Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry
2025 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 5
Safety of prehospital thrombolysis with non-immunogenic staphylokinase in 51021 patients with ST-elevation myocardial infarction: data from the FRIDOM-registry
2025 · S. N. Tereshchenko, S. F. Bagnenko, et al. · Russian Journal of Cardiology · 5
PDF
Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 4
Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3
Safety and efficacy of non-immunogenic staphylokinase in elderly patients over 75 years old with ST-segment elevation myocardial infarction: FREEDOM registry data
2025 · S. N. Tereshchenko, S. F. Bagnenko, et al. · Russian Journal of Cardiology · 3
Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT
2025 · I.I. Zatevakhin, A.V. Chupin, et al. · Angiology and vascular surgery · 3
Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 2
Prognostic outcome of intravenous thrombolysis with non-immunogenic staphylokinase in patients aged ≥ 60 years with acute ischemic stroke by THRIVE scale
2025 · Nikolay A. Shamalov, Zhanna Yu. Chefranova, et al. · Journal of Thrombosis and Thrombolysis · 2
Fortelyzin in the treatment of minor acute ischemic stroke according to a subanalysis of the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Predicting the safety of intravenous thrombolysis with Fortelyzin in patients over 60 years of age with ischemic stroke using the THRIVE scale
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Works count: 17
Citation count: 113
H-index: 6
I10-index: 3
Year
Topic
Type